Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply

被引：0
|
作者：
Ogawa, Eiichi [1 ,2 ]
机构：
[1] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Japan
[2] Kyushu Univ Hosp, Dept Gen Internal Med, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 08期
关键词：
D O I：
10.1111/apt.17693
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Ogawa et al papers. To view these articles, visit and
引用
收藏
页码：845 / 846
页数：2
相关论文
共 50 条
  • [31] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis
    Huang, Rui
    Liu, Jiacheng
    Wang, Jian
    Wu, Chao
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1040 - 1041
  • [32] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply
    Yip, Terry C. -F.
    Wong, Grace L. -H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 315 - 316
  • [33] Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma
    Shin, Hye Sun
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Baatarkhuu, Oidov
    Ahn, Sang Hoon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) : 1528 - 1534
  • [34] Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antivirals
    Cho, H.
    Ahn, H.
    Lee, D. H.
    Lee, J. -H.
    Jung, Y. J.
    Chang, Y.
    Nam, J. Y.
    Cho, Y. Y.
    Lee, D. H.
    Cho, E. J.
    Yu, S. J.
    Lee, J. M.
    Kim, Y. J.
    Yoon, J. -H.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (06) : 707 - 717
  • [35] Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply
    Chen, Chien-Hung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (08) : 1106 - 1107
  • [36] EFFICACY OF LAMIVUDINE AND ENTECAVIR IN PATIENTS WITH HEPATITIS B VIRUS-RELATED ADVANCED HEPATOCELLULAR CARCINOMA
    Shin, Hye Sun
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Ahn, Sang Hoon
    HEPATOLOGY, 2011, 54 : 1046A - 1046A
  • [37] Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma
    Qi Weili
    Shen Junyi
    Zhang Yu
    Gao Fengwei
    Li Chuan
    中华医学杂志英文版, 2023, 136 (19)
  • [38] Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma
    Qi, Weili
    Shen, Junyi
    Zhang, Yu
    Gao, Fengwei
    Li, Chuan
    CHINESE MEDICAL JOURNAL, 2023, 136 (19) : 2362 - 2364
  • [39] Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy
    Dong, Wei
    Yan, Kai
    Yu, Hua
    Huo, Lei
    Xian, Zhihong
    Zhao, Yanqing
    Li, Jutang
    Zhang, Yuchan
    Cao, Zhenying
    Fu, Yong
    Cong, Wenming
    Dong, Hui
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [40] Reduced serum circRNA＿00000367 levels in hepatitis B virus-related hepatocellular carcinoma
    Ajuan Zeng
    Jiayi Ma
    Xiaoru Wang
    Rui Sun
    Lei Li
    Huiguo Ding
    Shanshan Wang
    Infection Control, 2024, 1 (03) : 69 - 77
12345